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Abstract Inhibition of ATP-sensitive K+ (KATP) channels by
ATP, a process presumably initiated by binding of ATP to the
pore-forming subunit, Kir6.2, is reduced in the presence of phos-
phoinositides (PPIs). Previous studies led to the hypothesis that
PPIs compromise ATP binding. Here, this hypothesis was
tested using puri¢ed Kir6.2. We show that PPIs bind puri¢ed
Kir6.2 in an isomer-speci¢c manner, that biotinylated ATP ana-
logs photoa⁄nity label puri¢ed Kir6.2, and that this labeling is
weakened in the presence of PPIs. Patch-clamp measurements
con¢rmed that these ATP analogs inhibited Kir6.2 channels,
and that PPIs decreased the level of inhibition. These results
indicate that interaction of PPIs with Kir6.2 impedes ATP-
binding activity. The PPI regulation of ATP binding revealed
in this study provides a putative molecular mechanism that is
potentially pivotal to the nucleotide sensitivity of KATP channels.
( 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
ATP-sensitive Kþ channels (KATP channels) are heteromeric
complexes of regulatory sulfonylurea receptor (SUR) subunits
and channel-forming Kir6 subunits [1,2]. KATP channels be-
come permeable to Kþ when intracellular ATP levels are re-
duced, thus linking the metabolic status of the cell to mem-
brane excitability and permeability. Membrane-bound
phosphoinositides (PPIs), which are versatile signaling mole-
cules, modulate KATP channels, including their ATP sensitiv-
ity [3^7]. Electrophysiological studies suggest that PPIs are an
essential determinant of the ATP sensitivity of KATP channels
in intact cells [8]. However, the physiological role of this mod-
ulation remains unclear, partly because its molecular nature is
poorly understood [9,10].
Theoretically, PPI modulation of KATP channels could re-
sult from direct interaction between the lipids and the channel
protein, or could be mediated indirectly through signal trans-
duction pathways. It is also possible that changes in lipid
composition could a¡ect KATP channels through a change in
the physical chemistry properties of the membrane. So far,
research on this subject has been largely restricted to electro-
physiological characterization of the e¡ects of PPIs on KATP
channels and mutants. However, such an approach has limi-
tations. For example, studies of single-channel function have
not yet determined whether PPIs alter ATP binding. In this
study, we used biochemical approaches to address this issue.
Our data show that PPIs speci¢cally bind to the channel-
forming subunit, Kir6.2, and reduce ATP-binding activity.
These observations indicate that compromised ATP binding
is a mechanism whereby PPIs reduce channel inhibition by
ATP. Competition between the binding of phosphatidylinosi-
tol bisphosphate (PIP2) and ATP to a peptide derived from
the C-terminal sequence of Kir6.2 was also reported recently
[11]. Our present results are consistent with these data and
further extend the ¢nding to include the whole Kir6.2 subunit.
A portion of this work was presented previously as an ab-
stract [12].
2. Materials and methods
2.1. Construction of plasmids encoding Kir6.2
A truncated form of the Kir6.2 subunit, Kir6.2vC35, was con-
structed using a PCR-based site-directed mutagenesis kit, ExSite
(Stratagene, CA, USA), in a mammalian expression vector,
pcDNA3.1 (Invitrogen, CA, USA). The Kir6.2vC35 sequence was
also subcloned into a yeast expression vector, pYES2/NT (Invitro-
gen), containing a GAL1 promoter for high-level inducible protein
expression by galactose and repression by glucose, for expression
with a (His)6-Xpress tag at its N-terminus for a⁄nity puri¢cation
and antibody recognition. Kir6.2vC35 without SUR subunits ex-
presses functional ATP-sensitive channels in mammalian [13] and
yeast cells [14]. For simplicity, in this study Kir6.2vC35 is referred
as Kir6.2v and the tagged Kir6.2vC35 as Kir6.2v+.
2.2. Heterologous expression in cultured mammalian cells
The pcDNA3.1-Kir6.2v vector was introduced into COS-1 cells
using a NovaFECTOR kit (VennNova, FL, USA). Transient expres-
sion of Kir6.2 typically peaked at 64^72 h after transfection [4].
2.3. Expression of Kir6.2 in yeast cells
Competent Saccharomyces cerevisiae NVSc1 cells (Invitrogen) were
transformed with pYES2/NT-Kir6.2v+ vector. This yeast strain is
auxotrophic for uracil so that the transformants with the vector con-
taining a URA3 auxotrophic gene could be selected on plates of ur-
acil-de¢cient SC minimal medium. Selected colonies were cultured in a
shaking incubator, and protein expression was induced by supplying
galactose to the medium. The cells were allowed to grow until reach-
ing OD600 2^3.
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2.4. Sodium dodecylsulfate^polyacrylamide gel electrophoresis (SDS^
PAGE) and immunoblotting
Protein samples either in liposomes or in solution were pretreated
for 10 min at 100‡C in 60 mM Tris^HCl, 25% glycerol, 2% SDS, 14
mM 2-mercaptoethanol, and 0.1% bromophenol blue at pH 6.8. Pro-
tein content was analyzed by SDS^PAGE in a discontinuous Tris/
glycine bu¡er system according to the Laemmli protocol in 0.75- or
1.5-mm-thick slab gels (9.5% acrylamide, 3% stacking gel). Gels were
stained with Coomassie blue or silver-staining methods. Molecular
weights of the samples were determined by comparison to markers
(Sigma, MO, USA). Immunoblotting was performed on nitrocellulose
membranes (S and S). Brie£y, proteins were transferred from gels to
the membrane in a semidry-blot device. Membranes were washed and
blocked in blocking bu¡er [3% bovine serum albumin (BSA) in Tris-
bu¡ered saline (TBS), Tris^HCl 20 mM, NaCl 150 mM, pH 7.5], and
then incubated with an adequately diluted primary antibody. The
primary antibody was recognized by a secondary antibody conjugated
with alkaline phosphatase (AP) or horseradish peroxidase. Strepta-
vidin-AP (Ambion, TX, USA) was used to speci¢cally recognize bio-
tinylated samples. The antibodies or streptavidin were visualized with
a color-developing kit (BioRad Labs, CA, USA), or chemilumines-
cent-staining kit, SuperSignal West Pico (Pierce, IL, USA) or CDP-
Star (Ambion). Stained protein bands were scanned and analyzed by
densitometry using Scion Image software.
2.5. Protein puri¢cation
A⁄nity chromatography was used to purify Kir6.2v+ from frac-
tionated yeast membrane samples. From 2 l of 24-h yeast culture, 6^
15 g wet weight of yeast was usually harvested. The cells were broken
with glass beads in a power-driven beater (BioSpec, OK, USA). The
suspension was brie£y centrifuged, and laid on a sucrose gradient
(18%, 25%, 30%, 35%, and 45% sucrose) in TED bu¡er (Tris^HCl
20 mM, EDTA 1 mM, DTT 1 mM, pH 7.4). After centrifugation at
35 000 r.p.m. for 3 h at 4‡C in a SW41 Ti rotor (Beckman), the
membrane fractions were collected at all gradient interfaces. Mem-
brane fractions with high content of Kir6.2v+ were pooled, diluted
with 4 volumes of cold water, and centrifuged again. The resulting
pellet was dissolved in 25 mM sucrose and 10 mM HEPES^KOH (pH
7.4). The collected membranes were solubilized with 8^20 mM
CHAPS, and protein concentration was determined by the Bradford
method. Kir6.2v+ was isolated by Ni2þ-chelate chromatography. The
solubilized membrane proteins were applied to a ProBond resin col-
umn (Invitrogen). Unbound proteins were washed from the column
with loading bu¡er and low concentrations of imidazole, and proteins
bound to the column were further eluted with high concentrations of
imidazole. Fractions with high Kir6.2v+ content were identi¢ed by
immunoblotting. Untagged Kir6.2v was obtained by incubating
Kir6.2v+ with an enterokinase, Enterokinase Max (Invitrogen), to
cleave the tags. The resulting Kir6.2v was then separated from the
enzyme and cleaved tags using an EK-Away resin kit (Invitrogen).
Whenever necessary, bu¡er and protein concentration were adjusted
by dialyzing in Slide-A-Lyzer Dialysis Cassettes (Pierce), and concen-
trating in Centricon centrifugal ¢lters (Millipore, MA, USA). Protein-
ase inhibitor, phenylmethylsulfonyl £uoride (0.1 mM), was included
during puri¢cation, and leupeptin (300 ng/ml) and pepstatin (1.4 Wg/
ml) were also included during the initial steps. The pH of all bu¡ers
was adjusted to 6.5^7.8 to avoid denaturation.
2.6. Incorporation of Kir6.2 into liposomes
De¢ned mixtures of phospholipids, after drying under a stream of
nitrogen, were dissolved at 50 mg/ml in bu¡er containing 8 mM
CHAPS. Solubilized Kir6.2v+ was added to make a ¢nal protein
concentration of V200 Wg/ml. CHAPS was extracted from the mix-
ture by overnight dialysis at 4‡C against an appropriate intravesicle
bu¡er, and this was repeated to remove residual detergent.
2.7. Photoreactive labeling
Freshly puri¢ed or incorporated Kir6.2 samples were diluted to 50
or 100 Wg/ml in TBS supplemented with 50 WM oxidized glutathione
at pH 7.4, into which photoa⁄nity analogs of ATP were added. The
reaction mixtures were incubated for 30 min on ice in covered glass
tubes. The mixtures were then irradiated at 254 nm for 45^90 s at
room temperature in a UV crosslinker (Stratalinker UV Crosslinker,
Model 2400, Stratagene). The lamp delivers UV light to the prepara-
tion tube at an intensity of V4 mW/cm2.
2.8. PPI-binding assay
Lipid-spotted membranes (Echelon Inc., UT, USA) were blocked
Fig. 1. Puri¢cation of Kir6.2 heterogeneously expressed in S. cerevisiae NVSc1 cells. A: (a) Western blot of isolated membrane fractions labeled
with anti-poly(His) antibody. Lanes 1^5 ^ samples from mock transformants; lanes 6^10 ^ samples from cells transformed with pYES2/NT-
Kir6.2v+. The samples (left to right) were collected from the interfaces of 18, 25, 30, 35, and 45% sucrose and from the bottom of the sucrose
gradient. (b) Coomassie blue-stained SDS^PAGE gel. B: SDS^PAGE gel showing the puri¢cation stages. Lane 1 ^ molecular weight marker;
lane 2 ^ blank; lane 3 ^ total membrane proteins; and lanes 4^12 ^ washes and eluates from the a⁄nity resin column. C: (a) Western blot of
puri¢ed Kir6.2v+ (lane 1) and a control protein (lane 2) labeled with anti-Kir6.2 antibody. (b) Western blotting with anti-Xpress antibody
against an Xpress recognition site on the tag before (lane 1) and after (lane 2) cleavage of the tag with enterokinase. (c) Coomassie blue-stained
SDS^PAGE gel. The arrows point to the Kir6.2 bands.
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for 1 h in TBST (TBS with 0.01% Tween 20) containing 3% BSA.
Solubilized Kir6.2 (1 Wg/ml) was incubated with the membrane for 30
min at 4‡C in the same bu¡er. The membranes were washed, incuba-
ted for 2 h with an antibody speci¢c for Kir6.2 fusion protein, and
then washed again. The membranes were subsequently incubated with
a secondary antibody conjugated with AP for 2 h and then visualized.
2.9. Patch-clamp recordings and analysis
The patch-clamp and data-acquisition system is a well-established
technique in our lab [7]. In inside-out patch-clamp experiments, the
intracellular solution contained (in mM): KCl 140, HEPES 5.5,
EGTA 2, pH 7.3 adjusted using KOH, and the extracellular solution
contained (in mM): NaCl 130, KCl 10, CaCl2 1.8, MgCl2 0.48,
HEPES 5.5, and pH 7.4.
3. Results
3.1. Puri¢cation of Kir6.2
Expression of Kir6.2v+ in yeast cells was detected using a
monoclonal anti-polyhistidine antibody (Sigma). Analysis of
the subcellular distribution by sucrose gradient ultracentrifu-
gation showed that Kir6.2v+ was most abundant in the plas-
ma membrane fraction (Fig. 1A, collected from interfaces of
35^45% sucrose) [15]. During the preliminary experiments,
three detergents, Triton X-100, Zwittergent 3-14, and
CHAPS, were tested to optimize recovery of Kir6.2v+. It
appears that 8 mM CHAPS (a concentration close to its
upper CMC limit) provided su⁄cient solubility and repeatable
results. Puri¢cation was monitored by SDS^PAGE of samples
taken from the various eluted fractions (Fig. 1B). Identity of
the puri¢ed Kir6.2v+ was con¢rmed by labeling with two
unrelated antibodies: a monoclonal anti-Xpress antibody (In-
vitrogen), and an anti-Kir6.2 antibody (Fig. 1C; Kir6.2 anti-
body was a gift from Dr. D.E. Clapham).
3.2. Isomer-speci¢c binding of PPIs to Kir6.2
The dot blot binding assay was used to examine whether
Kir6.2 interacts selectively with PPIs. Fig. 2 illustrates results
of the binding assay. Solubilized Kir6.2v+ in the detergent-
containing bu¡er bound most strongly to PIP2 isomers; it also
bound PIP3, PIP, phosphatidic acid, and phosphatidylserine
to various extents. In comparison, under this experimental
Fig. 2. Speci¢c binding between Kir6.2 and lipids. A: (a) Dot-blot assay with anti-Xpress antibody to detect binding of the tagged Kir6.2 with
lipids spotted on the membrane. (b) Dot blotting in the presence of both tagged and untagged Kir6.2 (1:10); the latter was obtained from en-
terokinase treatment. (c) Dot blotting of a protein (mock) unrelated to Kir6.2 but containing the same tag. B: Plot of density of the dots. Ab-
breviations used in the ¢gure: PI(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; PI(4,5)P2, phosphatidylinositol 4,5-bisphosphate; PI(3,5)P2,
phosphatidylinositol 3,5-bisphosphate; PI(3,4)P2, phosphatidylinositol 3,4-bisphosphate; PI(3)P, phosphatidylinositol 3-monophosphate; PI(4)P,
phosphatidylinositol 4-monophosphate; PI(5)P, phosphatidylinositol 5-monophosphate; PI, phosphatidylinositol phosphate; PE, phosphatidyl-
ethanolamine; PS, phosphatidylserine; PA, phosphatidic acid; PC, phosphatidylcholine; I(1,3,4,5)P4, inositol (1,3,4,5)-tetrakisphosphate.
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condition, binding of Kir6.2v+ to inositol tetrakisphosphate,
phosphatidylethanolamine, phosphatidylcholine, phosphati-
dylinositol phosphate, or solvent was insigni¢cant. Kir6.2v
without the tag (removed by enterokinase), retarded the bind-
ing of Kir6.2v+ (Fig. 2), con¢rming that the binding site(s) is
located speci¢cally on the Kir6.2 structure.
3.3. Photolabeling of Kir6.2 by ATP photoa⁄nity analogs and
e¡ect of PPIs
Three biotinylated ATP photoa⁄nity analogs (ALT Inc.,
KY, USA) were tested for speci¢c labeling of Kir6.2.
Kir6.2v+ transferred onto nitrocellulose membranes after re-
acting with either 2-azidoadenosine 5P-triphosphate [Q]-biotin
(2-N3-ATP[Q]bio) or adenosine 5P-triphosphate [Q]azidoanilide-
biotin (ATP-[Q]azidoanilide-bio) could be detected speci¢cally
with streptavidin (Fig. 3), whereas labeling with 8-azidoade-
nosine 5P-triphosphate [Q]-biotin resulted in poor speci¢city
(i.e. less contrast relative to the background; data not shown).
This result is consistent with a report that ATP-[Q]azidoanilide
was a better probe than 8-azidoadenosine 5P-triphosphate in
cell membrane preparations [16]. The amount of labeled
Kir6.2v+ was competitively reduced when either ATP or a
non-biotinylated ATP analog, ATP-[Q]azidoanilide, was in-
cluded in the reaction mix (Fig. 3). Inclusion of PIP2 but
not phosphatidylcholine in the reaction considerably reduced
the labeling of the solubilized Kir6.2v+. The ATP analogs
could also label Kir6.2v+ incorporated into phosphatidylcho-
Fig. 3. Speci¢c photoa⁄nity labeling of Kir6.2 by biotinylated ATP photoa⁄nity analogs. A: Inhibition of photolabeling of Kir6.2 by ATP.
Western blot of Kir6.2v+ photolabeled by 100 WM 2-N3-ATP-[Q]bio detected with streptavidin. Samples in lanes 1 and 2 were photoreacted in
the absence and presence of 10 mM ATP, respectively. B: Dose-dependent inhibition of photolabeling by unbiotinylated ATP analog. (a) West-
ern blot with streptavidin of Kir6.2v+ photolabeled by 100 WM of either 2-N3-ATP-[Q]bio or ATP-[Q]azidoanilide-bio in the presence of 0 (lanes
1, 5), 0.01 (lanes 2, 6), 0.2 (lanes 3, 7), and 1 mM (lanes 4, 8) of ATP-[Q]azidoanilide. (b) Coomassie blue-stained SDS^PAGE gel. (c) Plot of
density measured from B.
6
Fig. 4. E¡ect of phospholipids on photoa⁄nity labeling of Kir6.2
by ATP photoa⁄nity analogs. A: Western blots with streptavidin il-
lustrating the e¡ect of phosphatidylinositol 4,5-bisphosphate (a) and
phosphatidylcholine (b) on photoa⁄nity labeling. In both blots,
lane 1 is Kir6.2v+ photolabeled with 2-N3-ATP-[Q]bio in the ab-
sence of lipids, and lane 2 is in the presence of 100 WM lipids. Cor-
responding density plots are also given. B: Reduced photoa⁄nity
labeling of Kir6.2 in proteoliposomes containing PPIs. (a) Western
blotting with streptavidin of photolabeled Kir6.2v+ by 2-N3-ATP-
[Q]bio, in proteoliposomes composed of phosphatidylcholine/phos-
phatidylethnolamine (lane 1), and phosphatidylcholine/phosphatidy-
lethnolamine/PPIs (lane 2, PPIs extracted from bovine brain, Sig-
ma). (b) Corresponding SDS^PAGE gel stained with Coomassie
blue.
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line/phosphatidylethanolamine (1:5) liposomes. In paired ex-
periments, labeling was weaker when PPIs were included in
the proteoliposomes (Fig. 4).
3.4. Inhibition of Kir6.2 channels by ATP photoa⁄nity analogs
and e¡ect of PPIs
Functionally, we con¢rmed that the biotinylated ATP pho-
toa⁄nity analogs inhibited Kir6.2v channels as e¡ectively as
ATP (Fig. 5A). Application of PPIs (0.5 mg/ml) reduced the
channel inhibition by these ATP analogs (Fig. 5B) in a man-
ner similar to that described for ATP [7].
4. Discussion
Using puri¢ed Kir6.2, our study demonstrates that (1) both
PPIs and ATP analogs selectively interact with the Kir6.2
subunit, and (2) interaction with ATP is weakened in the
presence of PPIs. Previously, indirect electrophysiological evi-
dence led to the hypothesis that PPIs reduce ATP inhibition
by interfering with the ATP-binding process [7]. The present
results provide more direct evidence in support of this hypoth-
esis.
Electrophysiological as well as biochemical studies have in-
dicated that the primary binding site for ATP inhibition of
KATP channels resides on the Kir6.2 subunit. It has been
reported that ATP photoa⁄nity analogs can label Kir6.2 in
extracted cell membranes [16,17], and that ATP analogs can
bind to peptides derived from the C-terminal sequence of
Kir6.2 [18]. This is the ¢rst report that puri¢ed Kir6.2 can
be photolabeled by ATP analogs, and our results are compa-
rable to those obtained from cell membranes [17]. Also, this is
the ¢rst report to use biotinylated ATP photoa⁄nity analogs.
The labeling and channel inhibition data not only indicate
that these non-radioactive analogs are suitable for studying
the ATP-binding site of Kir6.2, but also further con¢rmed
the idea that the structural speci¢city of this binding is low.
Previous electrophysiological analyses have shown that
PPIs a¡ect Kir6.2v channels, suggesting that Kir6.2 contains
the primary site of channel^PPI interaction [7]. It has been
postulated that interaction between lipid headgroups and the
C-terminal region of Kir6.2 is essential for the e¡ect of PPIs
[4]. Mutagenesis analysis has implicated the involvement of
several residues of the C-terminal region in the e¡ect of
PPIs [4,19]. The hypothesis of direct lipid^channel interaction
has also received support from experiments that show binding
of PPIs with peptides derived from the C-terminal sequence
[11]. In this study we further demonstrate that PPIs selectively
bind puri¢ed Kir6.2. Yet must this information be interpreted
with caution because the interactions manifested by these ex-
periments may include unphysiological ones. The speci¢city
revealed by the dot-blot assay suggests that the binding of
PPIs to Kir6.2 varies in general with the electrostatic charac-
teristic of the lipid headgroup, which is consistent with the
e¡ects on channel activity [4]. These data indicate that the
Fig. 5. E¡ect of 2-N3-ATP-[Q]bio on Kir6.2 channel current. A: Reversible inhibition of Kir6.2v channel current by ATP and 2-N3-ATP-[Q]bio
in an inside-out patch. B,C: Channel inhibition by 2-N3-ATP-[Q]bio before (B) and after (C) 3-minute treatment with PPIs (0.5 mg/ml).
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interaction appears primarily between the hydrophilic surfaces
of Kir6.2 and lipids, and is therefore likely to also occur in
situ.
At present, two possible mechanisms have been proposed
for the e¡ect of PPIs on ATP inhibition. The ¢rst hypothesis
attributes the e¡ect to an indirect consequence of channel-
gating changes caused by PPIs [20]. According to this hypoth-
esis, as the result of longer openings in the presence of PPIs,
the channel becomes apparently less sensitive to ATP inhibi-
tion. We and others [7,8] o¡ered an alternative hypothesis :
that PPIs directly compromise ATP binding. The present re-
sults are clearly consistent with the hypothesis that direct in-
teraction of PPIs with Kir6.2 interferes with the ATP-binding
process, although they are not su⁄cient to let us postulate
how this interference takes place, and they do not disprove
the ¢rst hypothesis. Indeed, these two hypotheses are not nec-
essarily exclusive of each other. It is very possible that both
mechanisms account partly for the e¡ect of PPIs on ATP
inhibition.
In studies of the e¡ect of PPIs on KATP channels, use of
puri¢ed Kir6.2 allows for control of the lipid environment,
and thus for more robust analysis of PPI interaction with
the channel-forming protein. However, the use of puri¢ed
Kir6.2 in a de¢ned lipid environment has the potential to
distance the results from physiological signi¢cance. In this
study, the functional status of Kir6.2 as a channel has not
been systematically evaluated. The selective interactions with
ATP and PPIs, nonetheless, have indicated that puri¢ed
Kir6.2 retains the structural conformation necessary for
ATP and PPI binding. Puri¢ed Kir6.2 therefore appears to
be a useful model for structure-function study of these inter-
actions.
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